|
Short-Term Reduced Dietary Protein in ER+/HER2- Breast Cancer Patients During Neoadjuvant Chemotherapy
RECRUITINGN/ASponsored by Josephine Connolly-Schoonen
Actively Recruiting
PhaseN/A
SponsorJosephine Connolly-Schoonen
Started2026-11-02
Est. completion2028-10-30
Eligibility
Age18 Years – 75 Years
SexFEMALE
Healthy vol.Accepted
Locations1 site
View on ClinicalTrials.gov →
NCT07897344
Summary
This study will examine if a short-term, reduced protein diet for the 3-day period prior to and on the day of each of the first 4 chemotherapy cycles and 4 days prior to primary breast surgery is well tolerated and adhered to by patients with stage II or III estrogen receptor positive (ER+) human epidermal growth factor receptor negative (HER2-) breast cancer (BC) receiving neoadjuvant chemotherapy (NAC).
Eligibility
Age: 18 Years – 75 YearsSex: FEMALEHealthy volunteers accepted
Inclusion Criteria: * 18-75 years of age at time of consent * Stage II or III ER+ HER2- breast cancer patients scheduled to receive standard of care neoadjuvant chemotherapy * Willingness to consume study foods exclusively during the 20 days of prescribed diet Exclusion Criteria: * Any food allergy that may result in anaphylactic response or death (due to possible food allergen cross-contamination in the metabolic kitchen) * Habitual low protein intake, less than or equal to 1.0 g per kilogram adjusted body weight, based on a screening dietary habits questionnaire score * Vegans or vegetarians that consume dairy and or eggs * Pregnant or breastfeeding at the time of screening * Significant mental illness presenting challenges to follow directions and consume the controlled protein diet exclusively * Body mass index less than or equal to 18 kilograms over meter squared or greater than 35 kilograms over meter squared * Participating in another study with a diet intervention
Conditions3
Breast CancerCancerHormone Receptor Positive, HER2 Negative Breast Cancer
Locations1 site
Stony Brook Cancer Center
Stony Brook University Cancer Clinical Trials Office631-728-7425CancerClinicalTrials@stonybrookmedicine.edu
Find trials near these locations
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
Actively Recruiting
PhaseN/A
SponsorJosephine Connolly-Schoonen
Started2026-11-02
Est. completion2028-10-30
Eligibility
Age18 Years – 75 Years
SexFEMALE
Healthy vol.Accepted
Locations1 site
View on ClinicalTrials.gov →
NCT07897344